1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Nanga, R.
Brender, J.R.
Popovych, N.
Ramamoorthy, A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
Solution NMR structure of PAP248-286 in TFE
4561.464
Prostatic acid phosphatase
3.1.3.2
UNP residues 248-286
1
syn
polymer
PAP
no
no
GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY
GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
1
0
2010-12-29
1
1
2011-07-13
Solution structure of PAP248-286 in 50% TFE
BMRB
Y
PDBJ
2010-12-03
REL
REL
purchased from from a vendor
9606
human
Homo sapiens
sample
target function
1000
10
1
2D 1H-1H TOCSY
2D 1H-1H NOESY
1.2
mM
20
mM
10
%
[U-99% 2H]
30
%
[U-99% 2H]
7.5
ambient
298
K
torsion angle dynamics, simulated annealing
1
fewest violations
1.2 mM PAP248-286-1; 20 mM sodium phosphate-2; 10 % [U-99% 2H] D2O-3; 30 % [U-99% 2H] TFE-4; trifluoroethanol/water
trifluoroethanol/water
Guntert, Mumenthaler and Wuthrich
structure solution
CYANA
Guntert, Mumenthaler and Wuthrich
refinement
CYANA
Cornilescu, Delaglio and Bax
refinement
TALOS
Koradi, Billeter and Wuthrich
structure solution
Molmol
Goddard
chemical shift assignment
SPARKY
Goddard
data analysis
SPARKY
Laskowski and MacArthur
data analysis
ProcheckNMR
Laskowski and MacArthur
structure solution
ProcheckNMR
Bruker Biospin
collection
TOPSPIN
Bruker Biospin
processing
TOPSPIN
900
Bruker
Avance
Bruker Avance
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
HIS
3
n
3
HIS
3
A
LYS
4
n
4
LYS
4
A
GLN
5
n
5
GLN
5
A
LYS
6
n
6
LYS
6
A
GLU
7
n
7
GLU
7
A
LYS
8
n
8
LYS
8
A
SER
9
n
9
SER
9
A
ARG
10
n
10
ARG
10
A
LEU
11
n
11
LEU
11
A
GLN
12
n
12
GLN
12
A
GLY
13
n
13
GLY
13
A
GLY
14
n
14
GLY
14
A
VAL
15
n
15
VAL
15
A
LEU
16
n
16
LEU
16
A
VAL
17
n
17
VAL
17
A
ASN
18
n
18
ASN
18
A
GLU
19
n
19
GLU
19
A
ILE
20
n
20
ILE
20
A
LEU
21
n
21
LEU
21
A
ASN
22
n
22
ASN
22
A
HIS
23
n
23
HIS
23
A
MET
24
n
24
MET
24
A
LYS
25
n
25
LYS
25
A
ARG
26
n
26
ARG
26
A
ALA
27
n
27
ALA
27
A
THR
28
n
28
THR
28
A
GLN
29
n
29
GLN
29
A
ILE
30
n
30
ILE
30
A
PRO
31
n
31
PRO
31
A
SER
32
n
32
SER
32
A
TYR
33
n
33
TYR
33
A
LYS
34
n
34
LYS
34
A
LYS
35
n
35
LYS
35
A
LEU
36
n
36
LEU
36
A
ILE
37
n
37
ILE
37
A
MET
38
n
38
MET
38
A
TYR
39
n
39
TYR
39
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
C
OXT
TYR
TYR
39
39
0.271
0.019
1.229
1.500
N
2
A
A
C
OXT
TYR
TYR
39
39
0.271
0.019
1.229
1.500
N
3
A
A
C
OXT
TYR
TYR
39
39
0.271
0.019
1.229
1.500
N
4
A
A
C
OXT
TYR
TYR
39
39
0.271
0.019
1.229
1.500
N
5
A
A
C
OXT
TYR
TYR
39
39
0.271
0.019
1.229
1.500
N
6
A
A
C
OXT
TYR
TYR
39
39
0.271
0.019
1.229
1.500
N
7
A
A
C
OXT
TYR
TYR
39
39
0.271
0.019
1.229
1.500
N
8
A
A
C
OXT
TYR
TYR
39
39
0.271
0.019
1.229
1.500
N
9
A
A
C
OXT
TYR
TYR
39
39
0.271
0.019
1.229
1.500
N
10
A
A
C
OXT
TYR
TYR
39
39
0.271
0.019
1.229
1.500
N
1
A
ARG
10
-175.35
114.82
1
A
ILE
30
-174.10
81.88
1
A
PRO
31
-69.80
-178.70
1
A
TYR
33
-69.39
-172.33
1
A
LEU
36
-126.16
-69.92
2
A
ALA
27
-86.16
31.38
2
A
ILE
30
-168.38
78.14
2
A
TYR
33
-105.40
-169.31
2
A
ILE
37
-98.66
30.27
3
A
LYS
6
-174.85
149.24
3
A
GLU
7
-114.92
74.74
3
A
GLN
29
39.83
34.27
3
A
PRO
31
-69.68
-171.21
3
A
LYS
34
45.48
83.94
4
A
LYS
8
-177.11
111.37
4
A
ILE
30
64.66
74.89
4
A
LYS
35
-63.53
-70.95
4
A
LEU
36
-123.52
-66.52
5
A
LYS
6
-67.92
-173.40
5
A
THR
28
38.96
34.88
5
A
PRO
31
-69.71
-171.10
5
A
LYS
34
45.59
84.04
5
A
LYS
35
-78.65
-74.48
6
A
GLN
5
-108.01
57.25
6
A
ALA
27
-85.64
32.42
6
A
ILE
30
60.24
68.72
6
A
PRO
31
-69.77
-175.83
6
A
TYR
33
-65.26
-166.39
6
A
LEU
36
-53.55
-72.16
7
A
GLN
12
39.70
34.81
7
A
ALA
27
-86.21
31.30
7
A
THR
28
39.45
34.88
7
A
ILE
30
64.90
75.30
7
A
TYR
33
-60.07
-172.88
8
A
ARG
10
-171.10
128.85
8
A
ALA
27
-86.19
31.66
8
A
TYR
33
-61.99
-174.06
9
A
GLU
7
-134.74
-71.53
9
A
LEU
11
-63.67
-74.15
9
A
ILE
30
64.04
71.34
9
A
PRO
31
-69.86
-171.27
9
A
TYR
33
-69.96
-171.11
10
A
LYS
8
-118.41
66.00
10
A
THR
28
39.59
34.66
10
A
ILE
30
64.31
73.91
10
A
PRO
31
-69.80
77.88
10
A
TYR
33
-61.01
-168.19
10
A
LYS
35
-49.95
175.16
10
A
LEU
36
-129.57
-68.49
10
A
ILE
37
-66.27
-176.65
Prostatic acid phosphatase (E.C.3.1.3.2)
fewest violations, model 1
Solution NMR structure of PAP248-286 in 30% TFE
1
N
N
A
LEU
11
A
LEU
11
HELX_P
A
ASN
18
A
ASN
18
5
1
8
A
GLU
19
A
GLU
19
HELX_P
A
GLN
29
A
GLN
29
1
2
11
HYDROLASE
PAP248-286, SEVI, AMYLOID, HYDROLASE
PPAP_HUMAN
UNP
1
248
P15309
GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY
248
286
2L79
1
39
P15309
A
1
1
39